Equitable Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Buy |
5,081
+386
| +8% | +$30.2K | ﹤0.01% | 1086 |
|
|
2025
Q1 | $340K | Buy |
4,695
+846
| +22% | +$61.3K | ﹤0.01% | 1049 |
|
|
2024
Q4 | $285K | Sell |
3,849
-1,484
| -28% | -$110K | ﹤0.01% | 1059 |
|
|
2024
Q3 | $352K | Sell |
5,333
-1,772
| -25% | -$117K | ﹤0.01% | 983 |
|
|
2024
Q2 | $656K | Sell |
7,105
-36
| -0.5% | -$3.33K | 0.01% | 760 |
|
|
2024
Q1 | $682K | Buy |
7,141
+606
| +9% | +$57.9K | 0.01% | 713 |
|
|
2023
Q4 | $498K | Sell |
6,535
-1,959
| -23% | -$149K | 0.01% | 779 |
|
|
2023
Q3 | $588K | Sell |
8,494
-8,982
| -51% | -$622K | 0.01% | 669 |
|
|
2023
Q2 | $1.65M | Buy |
17,476
+6,554
| +60% | +$618K | 0.02% | 393 |
|
|
2023
Q1 | $904K | Sell |
10,922
-883
| -7% | -$73.1K | 0.01% | 494 |
|
|
2022
Q4 | $881K | Sell |
11,805
-3,369
| -22% | -$251K | 0.02% | 476 |
|
|
2022
Q3 | $1.25M | Buy |
15,174
+349
| +2% | +$28.8K | 0.02% | 355 |
|
|
2022
Q2 | $1.41M | Sell |
14,825
-4,200
| -22% | -$399K | 0.03% | 321 |
|
|
2022
Q1 | $2.24M | Buy |
19,025
+2,171
| +13% | +$256K | 0.04% | 268 |
|
|
2021
Q4 | $2.18M | Buy |
16,854
+570
| +4% | +$73.8K | 0.03% | 266 |
|
|
2021
Q3 | $1.84M | Buy |
16,284
+250
| +2% | +$28.3K | 0.03% | 276 |
|
|
2021
Q2 | $1.66M | Sell |
16,034
-9,150
| -36% | -$948K | 0.03% | 283 |
|
|
2021
Q1 | $2.11M | Sell |
25,184
-1,095
| -4% | -$91.6K | 0.04% | 236 |
|
|
2020
Q4 | $2.4M | Sell |
26,279
-1,816
| -6% | -$166K | 0.05% | 202 |
|
|
2020
Q3 | $2.24M | Buy |
28,095
+1,399
| +5% | +$112K | 0.06% | 189 |
|
|
2020
Q2 | $1.85M | Buy |
26,696
+7,250
| +37% | +$501K | 0.05% | 222 |
|
|
2020
Q1 | $1.22M | Buy |
19,446
+6,078
| +45% | +$382K | 0.04% | 238 |
|
|
2019
Q4 | $1.04M | Buy |
+13,368
| New | +$1.04M | 0.03% | 296 |
|